A study of capecitabine metronomic chemotherapy is non-inferior to conventional chemotherapy as maintenance strategy in responders after induction therapy in metastatic colorectal cancer

BACKGROUND: The aim of this study is to demonstrate that capecitabine metronomic chemotherapy is non-inferior to capecitabine conventional chemotherapy as maintenance treatment, in patients who have responded to 16–18 weeks first-line chemotherapy in metastatic colorectal cancer (mCRC). METHODS: The...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Trials
Autors principals: Shi, Min, Ma, Tao, Xi, Wenqi, Jiang, Jinling, Wu, Junwei, Zhou, Chenfei, Yang, Chen, Zhu, Zhenggang, Zhang, Jun
Format: Artigo
Idioma:Inglês
Publicat: BioMed Central 2020
Matèries:
Study Protocol
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC7059341/
https://ncbi.nlm.nih.gov/pubmed/32143730
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s13063-020-4194-6
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars